aTyr Pharma, Inc.ATYRNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-0.97
↓ 11% vs avg
Percentile
P38
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-0.87
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -0.97 | +76.1% |
| 2024 | -4.08 | -149.8% |
| 2023 | -1.63 | -44.1% |
| 2022 | -1.13 | -14.9% |
| 2021 | -0.99 | -1174.4% |
| 2020 | -0.08 | +79.2% |
| 2019 | -0.37 | -470.0% |
| 2018 | 0.10 | +355.8% |
| 2017 | -0.04 | -108.7% |
| 2016 | 0.45 | - |